Boston Scientific Executive Expects Top-Line Pressure Through 2027
The executive said pressure is expected to persist and make revenue and EPS growth challenging, excluding the Penumbra deal.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.